These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22768522)

  • 41. Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion.
    Kawamori D; Kulkarni RN
    Islets; 2009; 1(3):276-9. PubMed ID: 21099284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Perspective of new and future treatment of type 2 diabetes].
    Sasaoka T
    Nihon Rinsho; 2012 May; 70 Suppl 3():707-15. PubMed ID: 22768603
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B
    Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of dysregulated glucagon secretion in type 2 diabetes.
    D'Alessio D
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucagon antagonism as a potential therapeutic target in type 2 diabetes.
    Bagger JI; Knop FK; Holst JJ; Vilsbøll T
    Diabetes Obes Metab; 2011 Nov; 13(11):965-71. PubMed ID: 21615669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longevity of human islet α- and β-cells.
    Cnop M; Igoillo-Esteve M; Hughes SJ; Walker JN; Cnop I; Clark A
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():39-46. PubMed ID: 21824255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of alpha cell in islets on beta cell function].
    Cheng LY; Xu SQ; Zhang WJ
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):394-7. PubMed ID: 22242412
    [No Abstract]   [Full Text] [Related]  

  • 51. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I; Tudurí E; Ripoll C; Nadal A
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pancreatic alpha-cell dysfunction in diabetes.
    Burcelin R; Knauf C; Cani PD
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S49-55. PubMed ID: 18640586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spectrum of antidiabetic actions of GLP-1 in patients with diabetes.
    Vilsbøll T; Holst JJ; Knop FK
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):453-62. PubMed ID: 19748063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic islet alpha cell commands itself: secrete more glucagon!
    Gaisano HY; Leung YM
    Cell Metab; 2008 Jun; 7(6):474-5. PubMed ID: 18522828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dysregulation of glucagon secretion in diabetes and intra-islet insulin effect on alpha-cells].
    Kawamori D
    Nihon Rinsho; 2012 May; 70 Suppl 3():212-7. PubMed ID: 22768522
    [No Abstract]   [Full Text] [Related]  

  • 56. Growth factor signalling in the regulation of α-cell fate.
    Kawamori D; Akiyama M; Hu J; Hambro B; Kulkarni RN
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():21-30. PubMed ID: 21824253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. K(ATP)-channels and glucose-regulated glucagon secretion.
    Rorsman P; Salehi SA; Abdulkader F; Braun M; MacDonald PE
    Trends Endocrinol Metab; 2008 Oct; 19(8):277-84. PubMed ID: 18771934
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.